IGOR SLUKVIN, MD
Medical Practice at Highland Ave, Madison, WI
License number
Wisconsin 43049
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
600 Highland Ave, Madison, WI 53792
Phone
(608) 263-8437
(608) 262-6337 (Fax)
(608) 262-6337 (Fax)
Professional information
Dr. Igor Slukvin, Madison WI - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
University of Wisconsin Hospital and Clinics
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
UW Hospital Pathology Clinic
600 Highland Ave, Madison 53792
(608) 263-8437 (Phone)
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
UW Hospital Pathology Clinic
600 Highland Ave, Madison 53792
(608) 263-8437 (Phone)
Certifications:
Anatomic & Clinical Pathology, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University of Wisconsin Hospital and Clinics
600 Highland Ave, Madison 53792
UW Hospital Pathology Clinic
600 Highland Ave, Madison 53792
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
600 Highland Ave, Madison 53792
UW Hospital Pathology Clinic
600 Highland Ave, Madison 53792
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Education:
Medical School
Kiev Medical Institute
Graduated: 1984
Univ Wi Hosp
Kiev Medical Institute
Graduated: 1984
Univ Wi Hosp
Igor Ivanovich Slukvin, Madison WI
Specialties:
Pathology, Anatomic Pathology & Clinical Pathology, Clinical Pathology/Laboratory Medicine
Work:
University of Wisconsin at Madison
600 Highland Ave, Madison, WI 53792
600 Highland Ave, Madison, WI 53792
Education:
Kiev A A Bogomolets/Ukrainian State Institute (1984)
Generation Of Mature Myelomonocytic Cells Through Expansion And Differentiation Of Pluripotent Stem Cell-Derived Lin-Cd34+Cd43+Cd45+Progenitors
US Patent:
2010008, Apr 1, 2010
Filed:
Sep 24, 2009
Appl. No.:
12/586600
Inventors:
Igor I. Slukvin - Verona WI, US
Maksym A. Vodyanyk - Madison WI, US
Maksym A. Vodyanyk - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C12N 5/00
US Classification:
435377, 435325
Abstract:
A method for efficient generation of neutrophils, eosinophils, macrophages, osteoclasts, dendritic cells an Langerhans cells from human embryonic stem cells is disclosed.
Generation Of Clonal Mesenchymal Progenitors And Mesenchymal Stem Cell Lines Under Serum-Free Conditions
US Patent:
2010026, Oct 14, 2010
Filed:
Mar 18, 2010
Appl. No.:
12/726814
Inventors:
Maksym A. Vodyanyk - Madison WI, US
Igor I. Slukvin - Verona WI, US
Igor I. Slukvin - Verona WI, US
International Classification:
C12N 5/0775
US Classification:
435354, 435363, 435366, 435325
Abstract:
Methods for obtaining multipotent Apelin receptor-positive lateral plate mesoderm cells, mesenchymal stem cells, and mesangioblasts under serum-free conditions are disclosed.
Multipotent Lymphohematopoietic Progenitor Cells
US Patent:
2012004, Feb 16, 2012
Filed:
Jul 29, 2011
Appl. No.:
13/194623
Inventors:
Igor I. Slukvin - Verona WI, US
Maksym A. Vodyanyk - Madison WI, US
James A. Thomson - Madison WI, US
Maksym A. Vodyanyk - Madison WI, US
James A. Thomson - Madison WI, US
International Classification:
C12N 5/0789, C12Q 1/68, G01N 33/53, C12Q 1/32, C12N 5/071, C12Q 1/02
US Classification:
435 612, 435366, 435372, 435 29, 435 71, 435 26
Abstract:
This invention relates to hematopoietic precursors derived from human embryonic stem cells. In the culture of differentiated cells from human ES cells, the fully committed hematopoietic precursors are CD34+ and CD43+ but not CD45+. If the cells are cultured until they express CD45, then the cells lose the ability to produce differentiated cells of the lymphoid lineages.
Method Of Forming Dendritic Cells From Embryonic Stem Cells
US Patent:
7811821, Oct 12, 2010
Filed:
May 31, 2006
Appl. No.:
11/443608
Inventors:
Igor I. Slukvin - Verona WI, US
James A. Thomson - Madison WI, US
Maksym A. Vodyanyk - Madison WI, US
Maryna E. Gumenyuk - Madison WI, US
James A. Thomson - Madison WI, US
Maksym A. Vodyanyk - Madison WI, US
Maryna E. Gumenyuk - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C12N 5/00, C12N 5/02, C12N 5/071
US Classification:
435377, 435373, 435366, 435372, 435385
Abstract:
This invention relates to the culture of dendritic cells from human embryonic stem (ES) cells. Human ES cells are first cultured into hematopoietic cells by co-culture with stromal cells. The cells now differentiated into the hematopoietic lineage are then cultured with GM-CSF to create a culture of myeloid precursor cells. Culture of the myeloid precursor cells with the cytokines GM-CSF and IL-4 causes functional dendritic cells to be generated. The dendritic cells have a unique phenotype, as indicated by their combination of cell surface markers.
Multipotent Lymphohematopoietic Progenitor Cells
US Patent:
8034613, Oct 11, 2011
Filed:
Sep 14, 2006
Appl. No.:
11/520871
Inventors:
Igor I. Slukvin - Verona WI, US
Maksym A. Vodyanyk - Madison WI, US
James A. Thomson - Madison WI, US
Maksym A. Vodyanyk - Madison WI, US
James A. Thomson - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C12N 5/00
US Classification:
435325, 435375, 435377
Abstract:
This invention relates to hematopoietic precursors derived from human embryonic stem cells. In the culture of differentiated cells from human ES cells, the fully committed hematopoietic precursors are CD34+ and CD43+ but not CD45+. If the cells are cultured until they express CD45, then the cells lose the ability to produce differentiated cells of the lymphoid lineages.
Method Of Forming Myeloid Precursor Cells From Human Embryonic Stem Cells
US Patent:
8133732, Mar 13, 2012
Filed:
Sep 7, 2010
Appl. No.:
12/876830
Inventors:
Igor I. Slukvin - Verona WI, US
James A. Thomson - Madison WI, US
Maksym A. Vodyanyk - Madison WI, US
Maryna E. Gumenyuk - Madison WI, US
James A. Thomson - Madison WI, US
Maksym A. Vodyanyk - Madison WI, US
Maryna E. Gumenyuk - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C12N 5/00, C12N 5/02, C12N 5/071
US Classification:
435377, 435373, 435366, 435372, 435385
Abstract:
This invention relates to the culture of dendritic cells from human embryonic stem (ES) cells. Human ES cells are first cultured into hematopoietic cells by co-culture with stromal cells. The cells now differentiated into the hematopoietic lineage are then cultured with GM-CSF to create a culture of myeloid precursor cells. Culture of the myeloid precursor cells with the cytokines GM-CSF and IL-4 causes functional dendritic cells to be generated. The dendritic cells have a unique phenotype, as indicated by their combination of cell surface markers.
Erythroid Cells Producing Adult-Type Β-Hemoglobin Generated From Human Embryonic Stem Cells
US Patent:
8158422, Apr 17, 2012
Filed:
Feb 8, 2007
Appl. No.:
11/672724
Inventors:
Igor I. Slukvin - Verona WI, US
James A. Thomson - Madison WI, US
Maksym A. Vodyanyk - Madison WI, US
Maryna E. Gumenyuk - Madison WI, US
James A. Thomson - Madison WI, US
Maksym A. Vodyanyk - Madison WI, US
Maryna E. Gumenyuk - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C12N 5/00, C12N 5/02
US Classification:
435377
Abstract:
Methods and compositions of erythroid cells that produce adult β-hemoglobin, generated by culturing CD31+, CD31+/CD34+ or CD34+ cells from embryonic stem cells under serum-free culture conditions.
Angiohematopoietic Progenitor Cells
US Patent:
2013005, Mar 7, 2013
Filed:
Aug 21, 2012
Appl. No.:
13/590591
Inventors:
Igor Slukvin - Verona WI, US
Maksym Vodyanyk - Madison WI, US
Maksym Vodyanyk - Madison WI, US
International Classification:
C12N 5/071, A61P 9/10, A61P 7/00, A61P 9/00, C12Q 1/02, A61K 35/12
US Classification:
424 937, 435366, 435 29
Abstract:
A purified human cell population of subsets of angiohematopoietic progenitor cells, wherein the population is at least 94% pure and wherein the cells are selected with cell markers selected from the group of KDR, APLNR, VE-cadherin, PDGFRα, CD31, CD235a, CD73, CD43, and CD41a.